1. Home
  2. HUM vs DGX Comparison

HUM vs DGX Comparison

Compare HUM & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humana Inc.

HUM

Humana Inc.

HOLD

Current Price

$198.75

Market Cap

22.5B

Sector

Health Care

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$198.49

Market Cap

23.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUM
DGX
Founded
1961
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5B
23.1B
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
HUM
DGX
Price
$198.75
$198.49
Analyst Decision
Hold
Buy
Analyst Count
20
12
Target Price
$237.65
$208.92
AVG Volume (30 Days)
1.5M
646.7K
Earning Date
04-29-2026
04-21-2026
Dividend Yield
1.79%
1.74%
EPS Growth
N/A
13.78
EPS
9.84
8.75
Revenue
$129,664,000,000.00
$11,035,000,000.00
Revenue This Year
$25.34
$7.53
Revenue Next Year
$6.11
$3.77
P/E Ratio
$20.15
$22.63
Revenue Growth
10.11
11.78
52 Week Low
$163.11
$160.02
52 Week High
$315.35
$213.50

Technical Indicators

Market Signals
Indicator
HUM
DGX
Relative Strength Index (RSI) 67.02 50.95
Support Level $165.21 $194.09
Resistance Level $285.02 $203.96
Average True Range (ATR) 6.87 4.21
MACD 4.50 0.17
Stochastic Oscillator 88.19 57.61

Price Performance

Historical Comparison
HUM
DGX

About HUM Humana Inc.

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: